VALERY N LIPENKO
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology BEDFORD, TX NPI 1982604427
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology TX ABBVIE INC. All categories
General Payments — all program years on this page
$185,064.79
- Category: General Payments
- Program years: PY2018–2024
- Record count: 815
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $11,438.12 across 94 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,268.75 | 3 |
| Food and Beverage | $1,999.33 | 83 |
| Travel and Lodging | $1,170.04 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $9,414.44 | 37 |
| Medtronic, Inc. | $975.43 | 11 |
| PFIZER INC. | $157.84 | 9 |
| Lilly USA, LLC | $132.93 | 2 |
| EMD Serono, Inc. | $112.54 | 5 |
| Mallinckrodt Hospital Products Inc. | $71.18 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $61.66 | 3 |
| Aucta Pharmaceuticals, Inc. | $60.03 | 2 |
| Teva Pharmaceuticals USA, Inc. | $58.40 | 2 |
| HARMONY BIOSCIENCES LLC | $54.74 | 3 |
| TG THERAPEUTICS, INC. | $53.33 | 2 |
| Amneal Pharmaceuticals LLC | $49.04 | 3 |
| Abbott Laboratories | $40.10 | 2 |
| LivaNova USA, Inc. | $32.96 | 2 |
| UCB, Inc. | $30.30 | 1 |
| Cadwell Industries, INC | $27.97 | 1 |
| Octapharma USA, Inc. | $27.94 | 1 |
| Biogen, Inc. | $22.74 | 1 |
| GE HEALTHCARE | $20.84 | 1 |
| Sumitomo Pharma America, Inc. | $17.22 | 1 |
| Nevro Corp. | $16.49 | 1 |
By program year
Records — PY2024 (94)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.